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Hereditary renal amyloidosis caused by a new variant lysozyme resulting in amyloidosis has continued to increase. Most
in a French family. forms of hereditary amyloidosis have multisystemic dis-
Background. The number of proteins with mutations result- tribution. The most frequent form of hereditary amy-ing in amyloidosis has continued to increase. Five proteins—
loidosis is associated with variant forms of transthyretin,transthyretin, fibrinogen -A chain, apolipoprotein AI, lyso-
but several other proteins (such as fibrinogen -A chain,zyme, apolipoprotein AII, cystatin C and gelsolin—can be asso-
ciated with hereditary amyloidosis involving the kidney. apolipoprotein AI (apoAI), lysozyme, apolipoprotein AII,
Methods. A French family with a history of autosomal domi- cystatin C and gelsolin) also are responsible for diverse
nant hereditary amyloidosis with early sicca syndrome and ne- clinical forms [2–7]. Clinically, transthyretin amyloidosisphropathy leading to renal failure after the fifth to, the seventh
is characterized by peripheral neuropathy, restrictivedecade was studied. Several tissue specimens obtained from
cardiomyopathy, eye, gut and renal involvement. Fibrin-the proband and his relatives were examined. Immunohisto-
chemistry was performed on paraffin embedded sections using ogen -A chain amyloidosis is characterized by a pre-
the indirect immunoperoxidase technique. We searched for muta- dominance of renal failure, while apolipoprotein A1 mu-
tions in the five exons and flanking introns of the lysozyme gene. tations are responsible for various clinical presentations
Results. Amyloid deposits from the bowel, labial salivary
including renal, hepatic, cardiac, cutaneous and laryngealgland and kidney were intensively stained by anti-lysozyme anti-
involvement. Gelsolin amyloidosis is restricted to cranialbody. Sequence analysis of lysozyme exon 2 from the affected
individuals revealed a nucleotide substitution predicting a sub- neuropathy and skin disease. Rare homozygous patients
stitution of the amino acid at position 64 in the mature protein have overt amyloid nephropathy leading to renal failure.
from tryptophane, an aromatic residue to the cationic residue Only two lysozyme mutations, I56T and D67H, have
arginine (W64R).
been reported thus far to be associated with hereditaryConclusion. We report a novel mutation (W64R) of the lyso-
amyloidosis, in three families with diverse clinical presen-zyme that is associated with hereditary amyloidosis and promi-
nent nephropathy. Since the treatment of hereditary amyloidosis tations [5, 8–11]. We report a novel variant of lysozyme
greatly varies with the nature of the amyloid protein, thorough that causes a combination of amyloid digestive deposi-
characterization of the latter is crucial for the management of tion with sicca syndrome and amyloid nephropathy. Thor-
the disease.
ough characterization of the true nature of amyloid in
the settings of hereditary amyloidosis and prominent
renal involvement is crucial for appropriate managementHereditary amyloidosis is a group of late-onset autoso-
and treatment of the patients.mal dominant diseases with amyloid deposition in vari-
ous tissues [1]. The number of proteins with mutations
METHODS
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Fig. 1. Pedigree of the family with sicca syndrome and renal amyloidosis. Subjects with sicca syndrome or signs of renal disease are indicated by
solid symbols. Subject I-2 indicated with half solid symbol is presumed to have died of uremia. Identification of the W64R lysozyme variant by
direct sequencing. Sequence chromatograms of sense strands from proband IV-2 is represented. Double peaks of T and C at the first nucleotide
position of the codon TGG with the sense primer are shown in the proband.
of the jejunum appeared to be infarcted and was resected (normal value 4 to 13) and urinary lysozyme is 0.52
with inflammatory mesenteric lymph nodes. Histology mg/L. Biopsy of the transplanted kidney disclosed diffuse
disclosed amyloid deposits both in the lymph nodes and amyloid deposits and no signs of rejection. A second
in the muscular part of the small bowel. He recovered cousin of the proband (patient IV8), who is now 47, has
uneventfully. Amyloid deposits also were found in vascu- a nephrotic syndrome and her serum creatinine value is
lar wall of the rectum, along the liver sinusoids, and in 98 mol/L. She has no other sign of amyloidosis except
bone marrow. At the age of 54 his serum creatinine was ocular sicca syndrome. A third cousin of the proband
122 mol/L and since then the renal failure has pro- (patient IV13), now 63, has a long history of proteinuria
gressed regularly. There were no signs of peripheral neu- and a renal biopsy showed amyloid deposits. The patient
ropathy or cardiac involvement. Echocardiography did
has been treated with chronic hemodialysis since the agenot reveal any features of amyloid cardiopathy but did
of 57. Finally, in the youngest generation, two subjectsshow a mitral valve prolapse. Keratitis secondary to sicca
are clinically affected. Patient V1, who is now 38, hassyndrome developed. He initiated chronic hemodialysis
had oral sicca syndrome since the age of 12, and hisrecently and remains well.
labial salivary gland biopsy shows prominent amyloid
Kindred deposits. He remains free of proteinuria. Patient V3 has
ocular signs of sicca syndrome.The mother of the proband (III2) died of peritonitis
at the age of 30 (Fig. 1). The proband’s great-grandfather
Histology and immunohistochemistry(II2) died of uremia at the age of 48, as did his maternal
great-grandmother (I2) at the age of 30. One maternal Several specimens obtained from the proband and his
aunt (III3) also died of uremia at the age of 60 years, relatives were examined. All specimens were fixed either
whereas her sister and one brother died at an advanced in formalin or in Duboscq Brazil liquid (renal biopsies)
age without any known renal disease. and embedded in paraffin. Tissue sections were stained
Three first cousins of the proband are affected. In the by Congo red with and without pretreatment by potassium
first cousin (IV6), proteinuria was discovered when the permanganate according to Wright’s technique [12].
cousin was age 29. Renal biopsy showed amyloid depos-
Immunohistochemistry was performed on paraffin em-its. Renal disease progressed to the nephrotic syndrome
bedded sections using the indirect immunoperoxidase tech-and led to end-stage renal failure at the age of 38, when
nique after enzymatic digestion with proteinase K (15chronic hemodialysis was started. A renal transplant was
to 30 min at room temperature). A monoclonal antibodyperformed at age 39. The patient is now 56 and is asymp-
against amyloid A protein and a polyclonal antibodytomatic, with no episodes of graft rejection and no com-
against lysozyme (Dakopatts, Glostrup, Denmark) wereplication of immunosuppressive treatment. No sign of
employed at the dilutions of 1/10 and 1/100, respectively.amyloidosis, except ocular sicca syndrome, has appeared
Irrelevant monoclonal antibody and normal rabbit im-in the meantime. Daily proteinuria is now 0.5 g and se-
rum creatinine is at 150mol/L. Serum lysozyme is 15 mg/L munoglobulins were used as controls.
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DNA sequence analysis In an attempt to improve the ELISA signal-to-noise
detection, some fractions were concentrated by Sepha-Genomic DNAs were extracted from peripheral blood
dex 15 prior to being immunoassayed.leukocytes by a standard procedure after informed con-
sent of the available family members. The five exons and
flanking introns of the lysozyme gene were amplified by RESULTS
the polymerase chain reaction (PCR) using previously Histology and immunohistochemistry
published primers and conditions [5]. Each PCR product
Amyloid deposits were stained by Congo red and ex-was directly sequenced on both strands using a dye termi-
hibited characteristic dichroism after polarization. Pre-nator cycle sequencing kit (Perkin Elmer, Norwalk, CT,
treatment of the slides by potassium permanganate com-
USA) and the sequencing products were resolved on an
pletely abolished the congophilia and the dichroism
automatic fluorescent DNA sequencer ABI Prism 377 of the deposits. Amyloid deposits of the kidneys were
(Applied Biosystems, Valencia, CA, USA). The nucleo- mainly observed in the vessels, arterioles and glomeruli,
tide sequences of each exon were then compared with and more rarely in the interstitial tissue. By immunohis-
the published sequence of the lysozyme cDNA and the tochemistry, the deposits were intensively stained by
identified mutation was numbered according to the pub- anti-lysozyme antibody, (Figs. 2 and 3), while no fixation
lished cDNA sequence [13]. was observed with anti-amyloid A protein antibody.
Control slides were negative.Urine lysozyme analysis
Molecular lysozyme gene studyThe samples of the proband were dialyzed four times
against MilliQ H2O brought to pH 3.8 with dilute formic Sequence analysis of lysozyme exon 2 from the pro-
acid (dialysis tubing Spectrapor, MWCO 3500), and spun band (IV3) revealed a heterozygous single base-pair
down at 5000  g for five minutes. The supernatant was transition from T to C of the first nucleotide position of
collected, filtered through a 0.22m filter (Millipore, Bed- codon 82 (TGG/CGG). This nucleotide substitution
ford, MA, USA), and further purified by ion exchange changes the amino acid at position 64 in the mature
chromatography as described by Selsted and Martinez protein from tryptophane, an aromatic residue to the
[14]. An ion exchange chromatography was run from 50 cationic residue arginine (W64R). Analysis of the re-
mainder of the coding sequence did not disclose anymmol/L to 1 mol/L NaCl (Mono S H/R 5/5 column).
nucleotide variation when compared with the publishedRecombinant wild-type human lysozyme eluted around
sequence of the human lysozyme. The mutation W64R0.4 mol/L NaCl. The collected fractions were assayed
was detected at the heterozygous state in the three af-for their enzymatic activity, and then dialyzed against
fected family members available. In addition, none ofMilliQ H2O before being run on a Micromass LC-TOF
the unaffected family members (IV2, V2) nor the 80spectrometer. Samples were introduced using a nanoflow
unrelated individuals tested (160 chromosomes in total)electrospray probe with borosilicate glass capillaries pre-
carried this mutation, suggesting that it is not a polymor-pared in house [15]. Two microliters of solution con-
phism. Together these results support the novel theorytaining 3 mol/L of protein was used for each experi-
that the W64R mutation in the lysozyme gene is thement. Spectra were recorded for a period of 60 seconds,
likely disease-causing mutation.with no observable decrease in the mass/charge ratio of
the peaks. Urine lysozyme analysis
A urine sample was dialyzed four times against MilliQPlasma lysozyme analysis
water, and then fractionated by ion exchange chromatog-
The plasma samples were spun in Eppendorf tubes at raphy. The fractions were assayed for bactericidal activ-
13,000 rpm for five minutes and then separated by ion ity and measured by mass spectrometry after dialysis. Ac-
exchange chromatography as above. An enzyme-linked tivity was found in the fraction centered on the recombi-
immunosorbent assay (ELISA) immunoassay was then nant wild-type elution peak. Similarly, mass spectrome-
run according to the protocol, “Indirect ELISA for try analysis of all the urine fractions showed the presence
Monoclonal Antibodies using Peroxidase Conjugated of only the wild-type lysozyme, which appeared exactly
Secondary Antibody,” using a rabbit anti-human lyso- at the predicted molecular weight (14693 D; Fig. 4).
zyme antibody as a primary antibody (ref. A0099; Dako,
Plasma lysozyme analysisHamburg, Germany), and a mouse horseradish peroxi-
dase conjugated monoclonal secondary antibody (ref. Plasma samples collected by four different methods were
A2074; Sigma, St. Quentin Fallavier, France), both at a used: no precipitation, citrate precipitation, heparin pre-
1/1000 dilution. Body surface area (BSA) 5% was used cipitation, and ethylenediaminetetraacetic acid (EDTA)
in a blocking step. Samples were read by absorbance at precipitation. The samples were fractionated by ion ex-
change chromatography and analyzed by an ELISA im-450 nm after acid quenching.
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Fig. 2. Salivary gland biopsy from the son of
the proband. Anti-lysozyme antibody. Indi-
rect immunoperoxidase. Staining of the amy-
loid deposits along the glandular tubules, the
vessel walls and the interstitial tissue of the
minor salivary gland (250).
Fig. 3. Renal biopsy from a cousin of the pro-
band. Anti-lysozyme antibody. Indirect im-
munoperoxidase. Intensive staining of the glo-
merular and vascular amyloid deposits. Note
the fixation or the antibody on some of the
proximal tubular cells. (250).
munoassay using rabbit anti-human lysozyme as a primary dance between the presence of the lysozyme gene muta-
antibody, and horseradish peroxidase-conjugated mono- tion and the development of amyloidosis indicate that
clonal anti-rabbit antibody in the second step. A single the identified W64R mutation is probably responsible
elution peak was found containing human lysozyme im- for the disease in this family. In addition, none of the
munoreactivity, and mass spectrometry analysis of the unaffected family members nor the unrelated 160 chro-
corresponding fractions only detected the wild-type pro- mosomes carried this mutation, suggesting that it is not
tein (spectra similar to the one in Fig. 4 were obtained). a polymorphism. Moreover, polymorphisms in the lyso-
zyme gene appear to be rare [16].
The clinical presentation was almost universal amongDISCUSSION
affected members of the present kindred, with a longWe have found a new lysozyme variant associated with
history of sicca syndrome and renal disease. Dry mouthhereditary amyloidosis and prominent nephropathy in a
symptoms were the first signs of the disease and for mostFrench family. Although no tissue has become available
affected members of the family it began when they werefor extraction and characterization of the amyloid fibril
protein, immunohistochemistry results and the concor- youths, while keratoconjunctivitis sicca also occurred in
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Fig. 4. Mass/charge spectrum of wild-type human lysozyme purified by ion exchange chromatography from a urine sample.
some of them. Salivary infiltration by amyloid is known predominates in these three families, a wide spectrum of
clinical signs has been observed, even in families with thein many types of amyloidoses, including AL, AA and
ATTR, and constitutes the basis for labial biopsy [17, 18]. same lysozyme variant. As a matter of fact, in the first
family with the D67H variant, renal involvement is slowlyClinical signs of sicca syndrome, especially of early onset,
are uncommon [17, 18]. However, it is noteworthy that progressive and one patient is well eight years after renal
transplantation [8, 10]. Sicca syndrome due to amyloidkeratoconjunctivitis sicca revealed amyloid disease in the
family with the lysozyme 156T mutation [7]. Lysozyme is also is present in several patients of this kindred. Gastro-
intestinal amyloid is a serious localization leading to he-known to be present in many biological fluids, including
saliva, and it can be hypothesized that lysozyme salivary morrhagic and surgical complications. Although hepatic
amyloid deposits are massive, they did not result in overtproduction accounts for local amyloid deposition [1].
Amyloid nephropathy was prominent and almost uni- complications, a fact that differs strikingly from the other
family with D67H lysozyme amyloidosis who presentedversal among affected members of this kindred, although
the ages at which it was detected varied from 29 to 54. Re- with spontaneous hemorrhagic rupture of the liver [9].
In the I56T family, dermal petechiae were a marker ofnal disease seems to progress at a relatively slow pace, al-
beit with differing rates among members of the kindred. the disease, which was also essentially characterized by
renal involvement leading to renal failure, although vis-In the proband, end-stage renal failure was reached in
12 years, while in his cousin (III5) it was reached in 6 ceral amyloid was found in most organs with the excep-
tion of the heart [9]. Overall, clinical presentation ofyears. This latter patient has received a successful renal
transplant, as after a 17-year course, she has a functioning amyloid disease in our family with the W64R lysozyme
variant looks rather similar to that of Lanham’s D67Hgraft and no sign of amyloid extrarenal progression. A
recent kidney biopsy, however, shows prominent amy- family, with a milder severity of gastrointestinal involve-
ment. Indeed, intestinal deposits were discovered in theloid deposits that probably accounting for proteinuria
and moderate chronic renal failure. Such late recurrence proband during a surgical procedure when he was 47,
but he has since remained asymptomatic for abdominalof amyloid deposition in a transplanted kidney and the
absence of evidence of accumulation of multisystemic am- manifestations. The phenotype of patients affected with
lysozyme amyloidosis therefore appears to be quite vari-yloid deposits reflect a slow rate of amyloid deposition.
Until now, only three families, all of English origin, able between families even between those with the same
mutation.have been reported to be affected with hereditary lyso-
zyme amyloidosis. In two unrelated families the lyso- Two types of body fluids from the proband were stud-
ied in an attempt to isolate the mutated protein. In bothzyme variant is D67H [5, 8, 10, 11], and in the third one
the variant is I56T [5, 9]. Although renal involvement cases, only the wild-type protein was detected (Fig. 4).
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